TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,118,000 | +221.2% | 54,718 | +14.6% | 0.00% | – |
| Q1 2022 | $1,282,000 | +31.1% | 47,727 | +132.7% | 0.00% | – |
| Q4 2021 | $978,000 | -36.1% | 20,513 | -10.9% | 0.00% | – |
| Q3 2021 | $1,530,000 | -6.9% | 23,034 | +9.4% | 0.00% | – |
| Q2 2021 | $1,643,000 | -92.6% | 21,062 | -91.0% | 0.00% | -100.0% |
| Q1 2021 | $22,054,000 | -25.4% | 233,150 | -3.9% | 0.01% | -33.3% |
| Q4 2020 | $29,576,000 | +2094.1% | 242,720 | +1472.8% | 0.01% | – |
| Q3 2020 | $1,348,000 | +56.2% | 15,432 | +15.5% | 0.00% | – |
| Q2 2020 | $863,000 | +21.5% | 13,356 | -15.9% | 0.00% | – |
| Q1 2020 | $710,000 | -41.9% | 15,890 | -19.1% | 0.00% | – |
| Q4 2019 | $1,223,000 | – | 19,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |